###begin article-title 0
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Germline CDH1 deletions in hereditary diffuse gastric cancer families
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 777 786 777 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-silico</italic>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1149 1153 1149 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH3</italic>
###xml 1167 1171 1167 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1462 1466 1462 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1517 1521 1505 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1689 1693 1677 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Germline CDH1 point or small frameshift mutations can be identified in 30-50% of hereditary diffuse gastric cancer (HDGC) families. We hypothesized that CDH1 genomic rearrangements would be found in HDGC and identified 160 families with either two gastric cancers in first-degree relatives and with at least one diffuse gastric cancer (DGC) diagnosed before age 50, or three or more DGC in close relatives diagnosed at any age. Sixty-seven carried germline CDH1 point or small frameshift mutations. We screened germline DNA from the 93 mutation negative probands for large genomic rearrangements by Multiplex Ligation-Dependent Probe Amplification. Potential deletions were validated by RT-PCR and breakpoints cloned using a combination of oligo-CGH-arrays and long-range-PCR. In-silico analysis of the CDH1 locus was used to determine a potential mechanism for these rearrangements. Six of 93 (6.5%) previously described mutation negative HDGC probands, from low GC incidence populations (UK and North America), carried genomic deletions (UK and North America). Two families carried an identical deletion spanning 193 593 bp, encompassing the full CDH3 sequence and CDH1 exons 1 and 2. Other deletions affecting exons 1, 2, 15 and/or 16 were identified. The statistically significant over-representation of Alus around breakpoints indicates it as a likely mechanism for these deletions. When all mutations and deletions are considered, the overall frequency of CDH1 alterations in HDGC is approximately46% (73/160). CDH1 large deletions occur in 4% of HDGC families by mechanisms involving mainly non-allelic homologous recombination in Alu repeat sequences. As the finding of pathogenic CDH1 mutations is useful for management of HDGC families, screening for deletions should be offered to at-risk families.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C1">1</xref>
Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant disorder that accounts for <1% of all cases of gastric cancer (GC). Although uncommon, this disease constitutes an important health issue due to its severity, its high penetrance, early age at presentation and the unavailability of effective screening tools. Diffuse gastric cancer (DGC) is the most important cause of cancer lethality in mutation positive HDGC families with lobular breast cancer being a secondary medical concern (1).
###end p 4
###begin p 5
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C2">2</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C4">4</xref>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C5">5</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C6">6</xref>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C1">1</xref>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C7">7</xref>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C8">8</xref>
###xml 351 354 <span type="species:ncbi:9606">men</span>
###xml 370 375 <span type="species:ncbi:9606">women</span>
Heterozygous germline point or small frameshift mutations in E-cadherin gene (CDH1) [OMIM +192090], a calcium-dependent cell-to-cell adhesion molecule and a tumor suppressor protein, are the only germline molecular defect associated with HDGC (2-4). Overall, carriers of CDH1 germline mutations have a cumulative GC risk, before age 75, of 40-67% for men and 63-83% for women and a risk for lobular breast cancer of 39-52% (5,6). Clinical expression of the disease often occurs before the third decade of life (1), but pre-clinical multifocal tumors, which may have the potential for metastatic spread, are already present in the stomachs of young asymptomatic CDH1 mutation carriers (7,8).
###end p 5
###begin p 6
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C9">9</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C10">10</xref>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C4">4</xref>
###xml 807 808 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C6">6</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C11">11</xref>
Clinical criteria have been established, in 1999, by the International Gastric Cancer Linkage Consortium (IGCLC) to select families for mutation screening in the CDH1 gene, based mainly on early age of disease presentation and diffuse histology of the tumors (9). These have been later adapted in an attempt to enlarge the population to which this screening could apply, in countries with low incidence of GC (10). Overall, 30-40% of HDGC families harbor CDH1 germline mutations, but this frequency is highly variable between countries with different incidences of GC, with low incidence countries like UK, North America and Canada, displaying nearly 50% of HDGC mutation positive families, while high incidence countries like Portugal and Italy, displaying around 10% of HDGC mutation positive families (4,6,11).
###end p 6
###begin p 7
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C12">12</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C14">14</xref>
###xml 893 897 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1158 1162 1158 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1506 1511 1506 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 1516 1521 1516 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMSH2</italic>
###xml 1572 1575 1572 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 1645 1650 1645 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1655 1660 1655 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 1735 1741 1735 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 1773 1775 1773 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C15">15</xref>
###xml 1776 1778 1776 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C21">21</xref>
Approximately two-thirds of families, screened worldwide, remain genetically unexplained and the concern related with the management of CDH1 mutation negative gastric cancer families persists. Since the required samples for full genome linkage, in any GC family, are difficult to obtain, a candidate gene approach to identify novel susceptibility genes has been more frequently used. Putative tumor suppressor genes, which are commonly inactivated in sporadic GC and/or associated with GC development, could also represent good candidate susceptibility genes to familial GC. Previous studies including ours, however, have lead us to rule out RUNX3, Caspase-10, SMAD4, HPP1, and Desmoglein 2 as major GC predisposition genes in families with aggregation of gastric carcinoma (12-14). Virtually all diffuse gastric carcinomas, both hereditary and sporadic, independently of whether they carry a CDH1 mutation, display identical morphological features as well as aberrant patterns of expression of E-cadherin (unpublished data). As no other gene has been so far shown to play a major genetic role in the disease, we hypothesize that other genetic events at the CDH1 locus, potentially missed by standard screening techniques, such as large genomic rearrangements, deletions or insertions could be found in families with multiple cases of DGC. Examples of this type of molecular alterations have been recently reported for other cancer associated syndromes. Large genomic rearrangements have been described in hMLH1 and hMSH2 in 10-20% of HNPCC mutation negative families, in APC in 15% of FAP mutation negative families and in lower frequencies in BRCA1 and BRCA2 in breast cancer families initially identified as negative, as well as in CDKN2A in melanoma negative families (15-21).
###end p 7
###begin p 8
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 513 521 <span type="species:ncbi:9606">patients</span>
Based on these observations, we aimed at characterizing CDH1 genomic rearrangements in a large population of HDGC patients, negative for CDH1 point mutations. Moreover, by using a larger series of families screened for CDH1 point mutations and rearrangements, in five reference centers world-wide and arising in countries with different GC incidence rates, we aimed at clarifying the frequency of CDH1 germline alterations and its relationship with GC incidence as well as with clinical criteria for selection of patients at risk.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
Multiplex ligation-dependent probe amplification analysis for the CDH1 gene
###end title 10
###begin p 11
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
We collected, from five reference centers, 93 DNA samples from families with aggregation of DGC and negative for CDH1 germline point mutations. These families were selected based on their risk to carry a germline alteration in CDH1 and the clinical criteria described in Materials and Methods section.
###end p 11
###begin p 12
###xml 238 242 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 310 314 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 327 328 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F1">1</xref>
###xml 336 337 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB1">1</xref>
We found that six out of the 93 (6.5%) probands showed abnormal multiplex ligation-dependent probe amplification (MLPA) features when compared with the controls, displaying an approximately70% signal reduction in one or more exons of the CDH1 gene and, suggesting the presence of large deletions affecting the CDH1 locus (Fig. 1, Table 1). No abnormalities were observed in the remaining 87 probands.
###end p 12
###begin p 13
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
MLPA output from the six HDGC families carrying germline deletions of the CDH1 locus. The first 17 bars represent signal obtained with MLPA probes within the CDH1 gene. Please note that for exon 1, three probes were used (1a, 1b and 1c). CDH1 deletions are represented, in the graph, by smaller bars marked with arrows. Bars on the right hand-side represent results obtained with control probes for MLPA (n = 15).
###end p 13
###begin p 14
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Table summarizing HDGC families analyzed for large CDH1 rearrangements (gray columns) and compilation of frequency of CDH1 alterations indicating geographic origin grouped by GC incidence rates
###end p 14
###begin p 15
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
aThis frequency represents 6/93 CDH1 deletions found in negative families. The overall frequency of large CDH1 deletions is 3.8% (6/160).
###end p 15
###begin p 16
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F1">1</xref>
After reproducing these results in an independent MLPA reaction, we verified that four probands (families 1 to 4) presented deletions at the 5'-end of the gene: in three probands deletions encompassed at least exon 1, intron 1 and exon 2 and, in one proband a smaller deletion that encompassed one of the three probes designed for CDH1 exon 1 was found. The remaining two probands (families 5 and 6) displayed deletions at the further 3'end of the gene: in one proband a deletion of the genomic sequence encompassing exons 14 and 16 was observed, an in the other a deletion of exon 16 only was observed (Fig. 1).
###end p 16
###begin title 17
Fine mapping of the deletions breakpoints
###end title 17
###begin p 18
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F2">2</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB2">2</xref>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH3</italic>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 708 712 708 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 985 989 985 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1254 1258 1254 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1345 1346 1345 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F3">3</xref>
###xml 1463 1467 1463 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1474 1475 1474 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F3">3</xref>
A combination of array CGH and PCR was utilized to map the putative breakpoints in five of the six probands (Fig. 2). The array CGH indicated the regions of chromosome 16 at which the breakpoints were located. PCR primers were then designed to span the breakpoints and the resulting PCR products sequenced (Table 2). Family 1 and family 2 showed identical MLPA patterns as well as virtually identical array CGH results. Sequencing of the breakpoint revealed that these two families harbored an identical 193 593 bp deletion encompassing the full sequence of CDH3 and extending to position IVS2+57 595 in CDH1. Family 3 was found to carry a 5671 bp deletion with breakpoints at position -3809 upstream of the CDH1 transcription start site (TSS) and at position IVS2+742 in CDH1. Family 4 harbored a 150 bp deletion encompassing the TSS of CDH1, with breakpoints located 125 bp upstream and 25 bp downstream of the TSS. Array CGH was not done for this proband since the PCR encompassing CDH1 exon 1 produced both a normal sized and a shorter band that was visible by dHPLC and further used to clone the breakpoints for the deletion by direct sequencing. Family 5 carried an 8078 bp deletion ranging from IVS13-2738 to 20 bp downstream of the stop codon of CDH1, as confirmed by long-range PCR using specific primers flanking the breakpoints (Fig. 3A). Family 6 was found to carry an 828 bp deletion ranging from IVS15+3097 to 223 bp downstream of the stop codon of CDH1 (Fig. 3B).
###end p 18
###begin p 19
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB2">2</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Array CGH profiles obtained for HDGC families carrying large CDH1 deletions. Examples are shown for four of the six families. See Tables 2 and 3 for details on the deletion found in each family. Deletions are represented by dense areas of green dots on the left side of each panel. Vertical thick gray bars on the left represent genes in the genomic area surrounding the CDH1 locus and corresponding gene symbols are also shown. Smaller deletions in families#3 and #5 are pointed with black arrows. Please note the scale in Mb on the right, for chromosome position.
###end p 19
###begin p 20
###xml 63 64 63 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 80 81 80 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 104 109 <span type="species:ncbi:9606">human</span>
Sequencing chromatogram of the mapped breakpoints in family 5 (A) and family 6 (B). Comparison with the human genome reference sequence. (A) Deletion of 8078 bp without insertion of P or N nucleotides. (B) Deletion of 828 bp and insertion of a triplet at the breakpoint.
###end p 20
###begin p 21
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Summary of HDGC families displaying CDH1 germline deletions
###end p 21
###begin p 22
LBC, lobular breast cancer; PCa, pancreatic cancer; LCa, liver cancer.
###end p 22
###begin title 23
Bioinformatics analysis of breakpoints and deletion containing sequences
###end title 23
###begin p 24
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C22">22</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C23">23</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C24">24</xref>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C25">25</xref>
Assuming that deletions are more likely to occur due to recombination events, we analyzed the genomic sequences flanking the boundaries of these five deletions, which are predicted to constitute target regions for breaks and recombinations to occur. We performed a search for Alu elements which have been reported to mediate non-allelic recombination events in several other malignancies. Evidence for non-homologous end joining (NHEJ) and non-allelic homologous recombination (NAHR) has been described in atypical NF1 microdeletions. These deletions were traced back to short sequences with similarities to Alu elements near the deletion junction (22). Moreover, deletions in the PMP22 gene have been described to be a product of homologous recombination between AluS elements present in intronic regions of the gene (23). We also performed a search for the presence of cryptic sequences recognizable by the RAG1/2 recombinase near the breakpoints and the insertion of P and/or N nucleotides in the rejoining sites. Such sequence features, reminiscent of V(D)J recombination sites, are expected to indicate whether cleavage by the RAG1/2 recombinase may occur near these joining sites (24,25).
###end p 24
###begin p 25
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F4">4</xref>
###xml 625 626 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
###xml 633 634 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F4">4</xref>
In three families carrying two different deletions we found that deletions overlap Alu repeats (Table 3). In families 1 and 2, bearing the same deletion at chr16:67193822-67387415, both deletion boundaries fall within annotated Alu repeats, AluSp near the start and AluSg near the end. The sequences of the two repeats are highly similar (percentage identity >75%) (Table 3, Fig. 4A). In family 3, carrying a deletion at chr16:67324886-67330557, the start of the deletion maps inside an AluSx repeat while the end map into a repeat AluSg and, the sequences of these two repeats display an identity of approximately80% (Table 3, Fig. 4B).
###end p 25
###begin p 26
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 151 152 151 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Analysis of sequences flanking the deletion breakpoints. (A and B) Homology analysis of AluS type elements flanking deletions in families 1, 2 and 3. (C) Ensembl based scheme displaying the repetitive elements flanking the deletion in family 5.
###end p 26
###begin p 27
Deletion coordinates and distance from deletion ends to the closest Alu containing sequences
###end p 27
###begin p 28
For the deletion at chr16:67328695-67328844, present in family 4, an AluJo repeat is present 304 bp upstream from the start of the deletion, and another AluJo is present 1497 bp downstream the end of the deletion. The closest repeat external to the deletion is a MIR named MIRb, 1235 bp downstream of the end-point but no sequence identity can be seen in the -150/+50 and -50/+150 bp fragments centered, respectively, on the start and the end of the deletion. An interesting feature of this 150 bp deletion is the presence of microsinteny/microhomology around the breakpoints due to the presence of five nucleotides sequence (CTCTC) between the upstream and downstream breakpoints.
###end p 28
###begin p 29
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
###xml 297 298 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F4">4</xref>
###xml 445 446 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
Family 5 displays a deletion at chr16:67416845-67424923 that does not overlap Alu repeats, although it occurs in the proximity of this type of repetitive regions (Table 3). The closest repeats both upstream and downstream are AT rich sequences, approximately300 bp distant from the deletion (Fig. 4C). Moreover, 344 bp upstream of the deletion start a FLAM_C repeat exists and 442 bp downstream of the endpoint there is an AluJb sequence (Table 3). The alignment of the -150/+150 bp surrounding the deletion ends did not show any identity.
###end p 29
###begin p 30
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F3">3</xref>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
The deletion in family 6, at chr16:67424298-67425126, is unlikely to have been produced by homology-dependent mechanisms, since a small (3 bp) sequence insertion at the junction between the deletion breakpoints was identified (Fig. 3B). For this deletion, the closest Alu repeats found on both sides of the deletion are an AluSq 50 bp upstream and an AluJb 239 bp downstream of the deletion's start and end, which share a sequence identity >77% (Table 3).
###end p 30
###begin p 31
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In a range of +/-5 Mb flanking the five deletions reported in this study, we did not find evidence for the presence of RAG1/2 consensus sequences accompanied or not by the insertion of P and/or N nucleotides in the rejoining sites. Nevertheless, the presence of Alus overlapping 6 out of the 12 points analyzed (the ends of the six deletion sequences) is statistically significant (z-score 3.3, P-value 0.0005) as tested by performing a randomization analysis with 1000 random sampling of 12 random locations (see Materials and Methods).
###end p 31
###begin title 32
Clinical features of deletion-carrying HDGC families
###end title 32
###begin p 33
The proband in family 1 was a 61-year-old female of European Irish/German/Scottish/Danish ancestry presenting with lobular breast cancer. Her daughter and son, as well as a grand-daughter developed DGC at the age of 40, 37 and 28, respectively, and are already diseased. The deletion was only looked for in the proband that is currently alive.
###end p 33
###begin p 34
###xml 152 159 <span type="species:ncbi:9606">patient</span>
In family 2, the proband, of unknown origin but currently living in Canada, was a female who developed DGC at 38 and later at 43 years old and the only patient tested in this family. Her two sisters also developed DGC at the ages of 30 and 35, respectively, but were not tested for the presence of the same deletion.
###end p 34
###begin p 35
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F5">5</xref>
The presence of the same deletion in two different families could be explained two ways. Either of these families had a common ancestor or the deletions arose independently. To clarify this issue, we performed haplotype analysis with seven microsatellite markers surrounding the CDH1 gene and verified that an allele for each of the microsatellite markers was common between the two families, demonstrating the existence of a common ancestor carrying this deletion (Fig. 5).
###end p 35
###begin p 36
###xml 55 56 55 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 195 196 195 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 295 296 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Haplotype analysis of family 1 and family 2 probands. (A) Scheme of chromosome 16 with reference to microsatellite markers used in the haplotype analysis and to the breakpoints of the deletion. (B) Common haplotypes displayed by probands of family 1 and family 2 and proving a common ancestry. (C) Agarose gel of the PCR that allowed the mapping of the deletion, showing similar band sizes for probands in both families.
###end p 36
###begin p 37
The proband in family 3, was a 34-year-old female of European Lithuanian origin, with DGC. Her mother was also affected by the same disease at uncertain age, and her grand-father developed pancreatic cancer at the age of 43 and none of them was tested for the deletion. The proband in family 4, was a 40-year-old male of Hispanic origin who developed DGC at the age of 40. His 24-year-old brother died from exactly the same disease and his father died at 42 with a pancreatic cancer, neither has been tested for the deletion. Carrier tests have been performed in ten other family members and one of which was positive.
###end p 37
###begin p 38
###xml 31 38 <span type="species:ncbi:9606">patient</span>
###xml 406 413 <span type="species:ncbi:9606">patient</span>
In family 5, the proband was a patient of European ancestry, who developed DGC at 33 years. His two sisters developed DGC at 33 and 35 years. At least one second degree relative developed GC, but no more information was available. So far, only the proband was tested, but five other family members are currently being tested for the presence of the deletion. As for family 6, the proband was a 51-year-old patient of European ancestry who developed DGC. His mother died of GC of unconfirmed histology at age of 52. Two sisters were recently diagnosed with DGC by surveillance endoscopy, although only one of them was tested for the deletion and proved to be a carrier. This sister's offspring, constituted of two asymptomatic individuals, also tested positive for the deletion. Four other second degree relatives died of cancer, one with DGC, two of GC of unknown histology and one of lobular breast cancer.
###end p 38
###begin title 39
Clinical criteria, frequency of CDH1 alterations and GC incidence
###end title 39
###begin p 40
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
In the present study, we analyzed 93 families based on two clinical criteria: (i) three or more DGC in first degree relatives diagnosed at any age or; (ii) two or more GC in first degree relatives with at least one DGC diagnosed before age 50; and found that 6.5% of these families carry large CDH1 germline deletions.
###end p 40
###begin p 41
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
With the purpose of clarifying the relative contribution of germline CDH1 point mutations and deletions in a large series of families fulfilling the aforementioned criteria, we collected data not only on the 93 negative families, herein analyzed for genomic rearrangements, but also on 67 HDGC families carrying CDH1 point mutations, from five different reference centers, and originated from countries with low, moderate and high GC incidence rates.
###end p 41
###begin p 42
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F6">6</xref>
From the series of 160 probands, 73 (45.6%) were proved to carry germline CDH1 alterations: 41.9% point mutations and 3.8% large deletions (Fig. 6).
###end p 42
###begin p 43
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Frequency of CDH1 alterations in a series of 160 HDGC families, subdivided by GC incidence rates as well as by type of gene alteration (point or small frameshift mutations and large deletions).
###end p 43
###begin p 44
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F6">6</xref>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB1">1</xref>
In low incidence countries namely in the North America, Canada, UK and Holland, the frequency of germline CDH1 alterations was 51.6%, while in moderate (Germany) and high (Portugal and Italy) incidence countries the frequency of alterations was 25 and 22.2%, respectively (Fig. 6). Large deletions were only identified in countries with low incidence of GC and account for 9% of all CDH1 alterations in HDGC families from such countries (Table 1).
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
In this report, we demonstrate that germline large deletions affecting the CDH1 locus are one of the mechanisms underlying HDGC. Our data supports the addition of MLPA based screening for such deletions to clinical screening for CDH1 mutations.
###end p 46
###begin p 47
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 25 44 25 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1, hMSH2, BRCA1</italic>
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C18">18</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C19">19</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C21">21</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C26">26</xref>
The CDH1 locus, like the hMLH1, hMSH2, BRCA1, APC and CDKN2A loci, is a region susceptible to genomic rearrangements leading to increased cancer susceptibility (18,19,21,26).
###end p 47
###begin p 48
###xml 369 388 369 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1, hMSH2, BRCA1</italic>
###xml 410 413 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C18">18</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C19">19</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C26">26</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C27">27</xref>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PMP22</italic>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C23">23</xref>
###xml 946 951 946 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C28">28</xref>
###xml 1069 1073 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1225 1226 1225 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB3">3</xref>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
The analysis of deletions found in our HDGC patients, revealed that two out of five deletions showed extensive sequence identity between the two breakpoints, strongly suggesting that NAHR was the mechanism of their formation (Families 1, 2 and 3). The deletion breakpoints of these two deletions fall within Alu repeats similar to what has been previously reported for hMLH1, hMSH2, BRCA1 and infrequently for APC (18,19,26). Alu repetitive sequences have long been believed to give rise to genomic deletions promoting recombinational instability (27). PMP22 deletions have been described to be a product of homologous recombination between intronic AluS elements in hereditary neuropathies (23), but the type of Alu sequences involved in deleterious deletions underlying cancer-associated syndromes have not been systematically explored in the literature. Nevertheless, at least one of the Alu sequences located at large deletion breakpoints in hMLH1 gene are described to be of the AluSx type (28). In our study, we analyzed the type of Alu sequences associated with CDH1 large deletions in HDGC, and found that six breakpoints overlap AluS elements: three overlap AluSg, two overlap AluSp and one overlaps an AluSx (Table 3).
###end p 48
###begin p 49
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C29">29</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C30">30</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C31">31</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C32">32</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C33">33</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C34">34</xref>
###xml 1276 1278 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C35">35</xref>
###xml 1323 1327 1323 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 983 987 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
One of the deletions herein identified occurs in a context of microhomology and could have arisen by microhomology-mediated recombination, a mechanism of NHEJ. This mechanism is associated with very short stretches of sequence identity (a few bp) between the two ends of the breakpoint junctions (29,30), rather than with long stretches of sequence identity at these locations (31,32). Moreover, it involves the double strand breakage of DNA followed by end joining in the absence of extensive sequence homology. A similar microhomology-mediated intra-strand repair mechanism has been previously described to occur either in pathological conditions such as trisomy in a family displaying an inverted duplication/deletion of 2p25.1-25.3 (33) or in recombination events underlying genomic variation during evolution (34). The same putative mechanism underlying the type of deletion and end re-joining, found in this family, has been described in a recent report where the treatment of mice, with specific chemicals or radiation during late spermatogenic stages, generates very short deletions, duplications, or inversions with microhomology around breakpoints. The ligation by NHEJ mediated by microhomology, is raised in the aforementioned report, as the major path of repair (35), and provides insight on how this specific CDH1 deletion may have initially arisen.
###end p 49
###begin p 50
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C32">32</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C34">34</xref>
Another of our deletions is unlikely to have been produced by homology-dependent mechanisms, since a small sequence insertion (3 bp) at the junction between the deletion breakpoints was identified. Since no extensive homology exists in the vicinity of breakpoints, it is likely that this deletion have been mediated by NHEJ. Identical deletions involving small insertions (3, 4, 6 bp), of unknown origin at the site of the breakpoints, have been previously identified within copy number variants (CNVs) breakpoint-region sequences, in normal population (32,34).
###end p 50
###begin p 51
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C34">34</xref>
In contrast to all other CDH1 deletions described so far in this report, one does not seem to be caused by NAHR, microhomology-mediated recombination or small sequence insertions at the junction site. This deletion is flanked by upstream and downstream low complexity AT rich sequences, as well as FLAM_C repeat and an AluJb sequence. Similar features surrounding deletions have been previously described to occur in CNVs described in apparently normal individuals (34), but the mechanisms involved in their generation is not known. The AT rich sequences could mediate a microhomology-mediated deletion mechanism based on their base composition bias, though further evidence would be needed to prove this.
###end p 51
###begin p 52
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C32">32</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C34">34</xref>
Deletions found in HDGC families mainly fall into three separate classes: products of NAHR, in which recombination between Alu containing sequences leads to deletion of the sequence between them; products of microhomology-mediated recombination, a mechanism of NHEJ; and results of small insertions of unknown origin at the site of the breakpoint junction. These deleterious deletions in CDH1 appear as the pathogenic counterpart of apparently normal evolution generated CNVs (32,34).
###end p 52
###begin p 53
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F6">6</xref>
###xml 699 703 699 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 839 843 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 869 870 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP046F6">6</xref>
###xml 816 824 <span type="species:ncbi:9606">patients</span>
The probands studied (n = 160) fulfilled clinically used criteria for HDGC (see Materials and Methods). We found that 45.6% (73/160) of them displayed CDH1 alterations (Fig. 6). In comparison, only 7/123 (5.7%) of the probands of families who did not meet the above testing criteria, had point mutations or small frameshift mutations, and none had deletions detectable through MLPA (data not shown). Based on this analysis, we have demonstrated that the clinical criteria herein used (three or more DGC in first degree relatives diagnosed at any age or two or more GC in first degree relatives with at least one DGC diagnosed before age 50) will identify most families with HDGC associated germline CDH1 alterations, with a mutation pick up rate of approximately46%. Based on these criteria, approximately4% of HDGC patients display large CDH1 germline deletions (Fig. 6).
###end p 53
###begin p 54
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH3</italic>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH3</italic>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C36">36</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C37">37</xref>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C6">6</xref>
Two of the families shared the same large deletion that included the whole of the CDH3 gene and the first two exons of CDH1. Individuals with homozygous germline truncating mutations in the CDH3 gene present with hypotrichosis with juvenile macular dystrophy (HJMD) syndrome (36,37). Heterozygous carriers of such mutations are phenotypically normal and have not been reported to have increased GC risk. Haplotype analysis supports a shared ancestor as the source of the (chr16:67193822-67387415) in these two families. We have previously used this approach to demonstrate that recurrent HDGC associated CDH1 germline point mutations can arise from a common ancestor (6).
###end p 54
###begin p 55
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
In conclusion, 6.5% of probands from strictly defined HDGC families who previously tested negative for CDH1 mutations carried heterozygous germline deletions. As these can be readily identified using MLPA, an assay frequently used in clinical cancer genetics laboratories, we suggest that MLPA be added to the testing strategy for all families who meet clinical criteria for HDGC.
###end p 55
###begin title 56
MATERIALS AND METHODS
###end title 56
###begin title 57
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and families
###end title 57
###begin p 58
###xml 884 885 884 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP046TB1">1</xref>
###xml 946 950 946 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1012 1016 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1111 1112 1111 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C3">3</xref>
###xml 1113 1114 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C6">6</xref>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C10">10</xref>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C13">13</xref>
###xml 1121 1123 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C38">38</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C46">46</xref>
###xml 1494 1498 1494 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1549 1553 1549 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 315 320 <span type="species:ncbi:9606">Human</span>
The collection of clinical data and peripheral blood samples was approved by the appropriate Ethics Committee from each of the centers participating in this work: University of British Columbia, Vancouver, Canada; Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal; Department of Human Pathology and Oncology, Section of Surgical Oncology, Translational Research Laboratory, University of Siena, Italy; Institute of Pathology, Technische Universitat Munchen, Munich, Germany; Department of Oncology, University of Cambridge, Cambridge, UK. A series of 160 probands from families with aggregation of DGC was analyzed in this study, based on the following clinical criteria: (i) three or more DGC in first degree relatives diagnosed at any age or; (ii) two or more GC in first degree relatives with at least one DGC diagnosed before age 50 (see Table 1). From these 160 probands, 67 showed point mutations in the CDH1 gene and were used only for analysis of general frequency of CDH1 mutations within HDGC families. The majority of these families have been published elsewhere (3,6,10-13,38-46) except for 15 families from University of British Columbia, Vancouver, Canada (unpublished data DGH), six families from Department of Oncology, University of Cambridge, Cambridge (unpublished data CC) and two families from Technische Universitat Munchen, Munich, Germany (unpublished data GK). The remaining 93 probands belonged to families that tested negative for CDH1 germline point mutations. These were analyzed for CDH1 genomic rearrangements.
###end p 58
###begin p 59
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Peripheral blood leukocytes from the 93 negative probands were referred for analysis at the different centers. High molecular weight genomic DNA was isolated from all patients using standard methodologies.
###end p 59
###begin title 60
Multiplex ligation-dependent probe amplification
###end title 60
###begin p 61
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C47">47</xref>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 1091 1095 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 978 985 <span type="species:ncbi:9606">patient</span>
A series of 93 probands, negative for CDH1 germline point mutations, were tested for the presence of large genomic alterations at the CDH1 locus using MLPA. MLPA is a PCR-based technique for identifying gene dosage alterations, which has been previously described in detail (47). All reagents were provided by the manufacturer in a kit (SALSA P085 CDH1 MLPA kit; MRC-Holland, Amsterdam, Holland), and testing was performed according to the manufacturer's recommendations. The assay contains probes for all but one of the CDH1 exons. For technical reasons exon 8 has been excluded and exon 1 has three different probes. The assay was done according to manufacturer's instructions. Briefly, the probes were hybridized overnight at 60degreesC with 100 ng of germline DNA and subsequently ligated. Ten microliters of the ligation reaction was used in the PCR which contained FAM labeled primers. The PCR products were analyzed on an ABI 3130xL Genetic Analyzer. The output for each patient displayed a peak that corresponded to the amount of amplified ligated probe present for each exon of the CDH1 gene, along with several peaks representative of extragenic regions used for ligation and PCR monitoring controls. Peak heights for fragments corresponding to specific exons and control regions were binned, appended to a table, and then saved as a text file, all within the Applied Biosystems Genotyper software. The resulting data were analyzed using the Coffalyser software downloaded from MRC-Holland. Any exon with a decrease or increase in peak height of 70% was scored as a deletion or duplication, respectively. MLPA assays which showed a variation between peak ratios were repeated.
###end p 61
###begin title 62
Comparative genomic hybridization microarray
###end title 62
###begin p 63
###xml 594 599 <span type="species:ncbi:9606">human</span>
A CGH array strategy was done to confirm the deletions identified by MLPA and to identify the location of deletion breakpoints. Custom CGH arrays were designed using Agilent's eArray program. An 8x15K array format was generated with Agilent HD CGH Database Catalog Probes for coverage of chromosome 16: 066880834-067879823. Genomic DNA (1.5 microg) was labeled using the Agilent Genomic DNA Labeling Kit PLUS (Agilent Technologies, Santa Clara, CA). Samples labeled with Cy3 were co-hybridized with Cy5 labeled gender-matched normal reference gDNA (Promega, Madison WI) to custom 8x15K Agilent human CGH microarrays. Microarrays were washed with Agilent CGH wash buffers and scanned on an Agilent DNA Microarray Scanner. Images were analyzed using Agilent Feature Extraction (version 8.5) and data were analyzed using Agilent CGH Analytics (version 3.4.27).
###end p 63
###begin title 64
Breakpoint identification
###end title 64
###begin p 65
Based on the information obtained from the CGH array, primers were designed spanning the putative breakpoints for each case and used in long-range PCR. A table with primer sequences is supplied as ).
###end p 65
###begin title 66
Haplotype analysis
###end title 66
###begin p 67
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP046C11">11</xref>
###xml 521 539 521 539 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.gdb.org">http://www.gdb.org</uri>
Analysis was performed using the following microsatellite markers surrounding the CDH1 gene: D16S318, D16S3107, D16S3025, D16S496, D16S3067, D16S3095 and D16S752. Each marker was amplified and then analyzed on an ABI 3130xL Genetic Analyzer followed by analysis using Genemapper V7.0 software. Primer sequences for the microsatellite markers D16S3025, D16S496, D16S3095 and D16S752 have been previously reported (11). Sequences for the remaining markers, D16S318, D16S3107 and D16S3067 are listed in the genome database (http://www.gdb.org).
###end p 67
###begin title 68
Analysis of breakpoints sequence context
###end title 68
###begin p 69
###xml 199 236 199 236 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://biodev.cbm.fvg.it/remo/DEL.txt">http://biodev.cbm.fvg.it/remo/DEL.txt</uri>
Breakpoints were defined as a set of coordinates on the genome spanning the genomic sequence of the deletions. The coordinates have been loaded on the UCSC genome browser as a BED file accessible on http://biodev.cbm.fvg.it/remo/DEL.txt. Both automatic and manual bioinformatics analysis have been carried out in order to analyze the genomic context of these regions.
###end p 69
###begin p 70
###xml 142 154 142 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 142 154 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 204 209 <span type="species:ncbi:9606">Human</span>
###xml 980 985 <span type="species:ncbi:9606">human</span>
For each deletion we analyzed the closest repeats in a range of 1500 bp flanking the start/end points. Repeats were obtained from the Ensembl Homo sapiens core database version 50 and UCSC genome browser Human Mar. 2006 Assembly. Sequences in a range of -150/+50 bp flanking the start-point and -50/+150 bp flanking the end-point of the deletions have been collected in order to test the similarity around the breakpoints by using both clustalw and blast2 with default parameters. An interval of 5 Mb around the deletion start/end points has been analyzed in order to look for the presence of the RAG1 binding site on both strands by using a custom perl script and known consensus sequences (CACTGTG.{11,13}GGTTTTTGT,GGTTTTTGT.{11,13}CACTGTG, ACAAAAACC.{11,13}CACAGTG,CACAGTG.{11,13}ACAAAAACC,CACTGTG.{22,24}GGTTTTTGT,GGTTTTTGT.{22,24}CACTGTG,ACAAAAACC.{22,24}CACAGTG,CACAGTG.{22,24}ACAAAAACC). In order to perform randomization analysis we collected 150 000 random points on the human genome and calculated for each of them the distance from the closest Alu. The distribution of the distances has been trimmed in order to avoid considering points in poorly annotated regions and/or in gene deserts and/or in genomic gaps, which resulted nonetheless to be very far from Alus. We trimmed out all the points retaining a distance bigger than 4519 bp (the 1.5*IQR of the distribution of all the distances) from the closest Alu.
###end p 70
###begin title 71
SUPPLEMENTARY MATERIAL
###end title 71
###begin p 72
.
###end p 72
###begin title 73
FUNDING
###end title 73
###begin p 74
###xml 49 114 49 114 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The National Cancer Institute of Canada (Canadian Cancer Society)</grant-sponsor>
###xml 116 164 116 164 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The Michael Smith Foundation for Health Research</grant-sponsor>
###xml 174 226 174 226 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The Portuguese Foundation for Science and Technology</grant-sponsor>
###xml 246 270 246 270 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POCTI/SAU-OBS/58111/2004</grant-num>
###xml 272 295 272 295 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTDC/SAU-GMG/72168/2006</grant-num>
###xml 305 317 305 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ci&#234;ncia 2007</italic>
###xml 328 377 328 377 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sixth Framework Programme from European Union FP6</grant-sponsor>
###xml 392 411 392 411 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSHC-CT-2005-018754</grant-num>
###xml 414 437 414 437 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The Deutsche krebshilfe</grant-sponsor>
###xml 452 463 452 463 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10-1345-H&#214;2</grant-num>
###xml 469 492 469 492 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Istituto Toscano Tumori</grant-sponsor>
###xml 516 573 516 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gene expression profile and therapeutic implication in GC</italic>
###xml 575 631 575 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">From the clinical overview to the translational research</italic>
This work was supported by the following grants: The National Cancer Institute of Canada (Canadian Cancer Society); The Michael Smith Foundation for Health Research to D.H.; The Portuguese Foundation for Science and Technology-FCT (grant numbers POCTI/SAU-OBS/58111/2004, PTDC/SAU-GMG/72168/2006, Program Ciencia 2007 to C.O.); Sixth Framework Programme from European Union FP6 (grant number LSHC-CT-2005-018754); The Deutsche krebshilfe (grant number 10-1345-HO2) and Istituto Toscano Tumori (ITT) (Grant 2007 Ref: Gene expression profile and therapeutic implication in GC. From the clinical overview to the translational research). Funding to pay the Open Access charge was provided by National Cancer Institute of Canada Grant #018381 "The effect of E-cadherin mutations on gastric and breast cancer risk: from families to populations."
###end p 74
###begin title 75
Supplementary Material
###end title 75
###begin title 76
[Supplementary Data]
###end title 76
###begin title 77
ACKNOWLEDGEMENTS
###end title 77
###begin p 78
###xml 26 34 <span type="species:ncbi:9606">patients</span>
We gratefully acknowledge patients, families and their caregivers for their willing participation in this research project and who provided consent regarding use of the information obtained from the study.
###end p 78
###begin p 79
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 79
###begin title 80
REFERENCES
###end title 80
###begin article-title 81
Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy
###end article-title 81
###begin article-title 82
E-cadherin germline mutations in familial gastric cancer
###end article-title 82
###begin article-title 83
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin
###end article-title 83
###begin article-title 84
Genetics, pathology, and clinics of familial gastric cancer
###end article-title 84
###begin article-title 85
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families
###end article-title 85
###begin article-title 86
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer
###end article-title 86
###begin article-title 87
Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations
###end article-title 87
###begin article-title 88
Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
###end article-title 88
###begin article-title 89
Familial gastric cancer: overview and guidelines for management
###end article-title 89
###begin article-title 90
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria
###end article-title 90
###begin article-title 91
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management
###end article-title 91
###begin article-title 92
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients
###end article-title 92
###begin article-title 93
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 49 59 49 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caspase-10</italic>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
E-Cadherin (CDH1) and TP53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients
###end article-title 93
###begin article-title 94
Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer
###end article-title 94
###begin article-title 95
Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques
###end article-title 95
###begin article-title 96
MSH2 genomic deletions are a frequent cause of HNPCC
###end article-title 96
###begin article-title 97
MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer
###end article-title 97
###begin article-title 98
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMSH2</italic>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients
###end article-title 98
###begin article-title 99
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Large deletions of the APC Gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study
###end article-title 99
###begin article-title 100
Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark
###end article-title 100
###begin article-title 101
A Novel Type of Deletion in the CDKN2A Gene Identified in a Melanoma-Prone Family
###end article-title 101
###begin article-title 102
Evidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions
###end article-title 102
###begin article-title 103
Identification of Alu elements mediating a partial PMP22deletion
###end article-title 103
###begin article-title 104
Distinct DNA sequence and structure requirements for the two steps of V(D)J recombination signal cleavage
###end article-title 104
###begin article-title 105
Cryptic signals and the fidelity of V(D)J joining
###end article-title 105
###begin article-title 106
The contribution of germline rearrangements to the spectrum of BRCA2 mutations
###end article-title 106
###begin article-title 107
###xml 23 28 <span type="species:ncbi:9606">human</span>
Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment
###end article-title 107
###begin article-title 108
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations
###end article-title 108
###begin article-title 109
###xml 103 127 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Ionizing radiation and restriction enzymes induce microhomology-mediated illegitimate recombination in Saccharomyces cerevisiae
###end article-title 109
###begin article-title 110
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae Sae2- and Tel1-dependent single-strand DNA formation at DNA break promotes microhomology-mediated end joining
###end article-title 110
###begin article-title 111
###xml 65 70 <span type="species:ncbi:9606">human</span>
Paired-end mapping reveals extensive structural variation in the human genome
###end article-title 111
###begin article-title 112
###xml 43 48 <span type="species:ncbi:9606">human</span>
The fine-scale and complex architecture of human copy-number variation
###end article-title 112
###begin article-title 113
A familial inverted duplication/deletion of 2p25.1-25.3 provides new clues on the genesis of inverted duplications
###end article-title 113
###begin article-title 114
Small deletion variants have stable breakpoints commonly associated with alu elements
###end article-title 114
###begin article-title 115
###xml 27 31 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Germline translocations in mice: unique tools for analyzing gene function and long-distance regulatory mechanisms
###end article-title 115
###begin article-title 116
Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin
###end article-title 116
###begin article-title 117
Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome)
###end article-title 117
###begin article-title 118
Screening of E-Cadherin in gastric cancer families reveals germ-line mutations only in hereditary diffuse gastric cancer kindred
###end article-title 118
###begin article-title 119
Intragenic deletion of CDH-1 as the inactivating mechanism of the wild-type allele in a HDGC tumor
###end article-title 119
###begin article-title 120
Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer
###end article-title 120
###begin article-title 121
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer
###end article-title 121
###begin article-title 122
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family
###end article-title 122
###begin article-title 123
###xml 79 86 <span type="species:ncbi:9606">patient</span>
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation
###end article-title 123
###begin article-title 124
Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer
###end article-title 124
###begin article-title 125
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E-cadherin</italic>
E-cadherin is not frequently mutated in hereditary gastric cancer
###end article-title 125
###begin article-title 126
###xml 9 19 9 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E-cadherin</italic>
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer
###end article-title 126
###begin article-title 127
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
###end article-title 127

